Clinical Scientist, Jen Blankenship, PhD., presented at the 2022 Digital Biomarkers and Clinical Measures in Neurology conference to discuss the significant opportunities to advance Alzheimer’s Disease drug development with wearable and connected technology.
Overcome the challenges of digital solutions in early-stage clinical trials by building a systematic approach with these 4 steps:
Get the eBook and optimize your clinical trial with data from wearable sensors!
During this presentation, our Chief Science Officer, Kate Lyden, PhD., shares an example of one of the first regulated clinical trials that used a wearable sensor to monitor or measure a digital biomarker in a patient’s home setting. Watch Now
Hear how connected devices complement the overall objectives of DCTs to meet patients where they are at, reduce the burden of participating in clinical trials, and measure patients in environments that matter most to them. Watch Now
Listen to industry experts discuss the reasons behind and the missed opportunities from the slow adoption of digital clinical measures and provide examples of successful deployment of wearable and remote monitoring technologies to improve clinical outcomes in cancer patients. Watch Now
Kate Lyden, PhD., VivoSense Chief Science Officer; Jeremy Wyatt, CEO, ActiGraph; Andy Coravos, Co-founder and CEO, Elektra Labs; and Shyamal Patel give tips and share their experiences with managing wearable data. Watch Now
Uncover the data behind the development of B6ME™, a novel digital biomarker that uses wearable sensor technology to provide the additional granularity of patient functioning and novel movement and mobility-related endpoints. Watch Now
During this presentation, our our Chief Science Officer, Kate Lyden, PhD., and industry leaders share essential guidelines to start with the end in mind and take a comprehensive approach when validating new wearable solutions for clinical trials. Learn how best practice implementation will maximize the value of your data in the long term. Watch Now
During this presentation, our our Chief Science Officer, Kate Lyden, PhD., and industry leaders share essential guidelines to start with the end in mind and take a comprehensive approach when validating new wearable solutions for clinical trials. Learn how best practice implementation will maximize the value of your data in the long term. Watch Now
In this presentation, Dudley Tabakin, VivoSense CEO, discusses critical details about how to drive meaningful clinical trial data. He’ll share an internal study in which real-world respiration data were analyzed from 61 patients with Spinal Muscular Atrophy (SMA). Watch Now
